Stratos Wealth Partners LTD. Has $34,000 Position in Tilray Brands, Inc. $TLRY

Stratos Wealth Partners LTD. grew its holdings in Tilray Brands, Inc. (NASDAQ:TLRY) by 704.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 81,272 shares of the company’s stock after purchasing an additional 71,170 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in Tilray Brands were worth $34,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. KBC Group NV raised its holdings in Tilray Brands by 102.6% in the 1st quarter. KBC Group NV now owns 77,657 shares of the company’s stock valued at $51,000 after acquiring an additional 39,325 shares in the last quarter. Tradewinds Capital Management LLC raised its holdings in Tilray Brands by 2,038.6% in the 1st quarter. Tradewinds Capital Management LLC now owns 73,460 shares of the company’s stock valued at $48,000 after acquiring an additional 70,025 shares in the last quarter. Vontobel Holding Ltd. raised its holdings in Tilray Brands by 25.8% in the 1st quarter. Vontobel Holding Ltd. now owns 241,844 shares of the company’s stock valued at $159,000 after acquiring an additional 49,643 shares in the last quarter. Concurrent Investment Advisors LLC acquired a new position in Tilray Brands in the 1st quarter valued at approximately $50,000. Finally, Capital Management Associates Inc raised its holdings in Tilray Brands by 100.0% in the 1st quarter. Capital Management Associates Inc now owns 50,760 shares of the company’s stock valued at $33,000 after acquiring an additional 25,380 shares in the last quarter. 9.35% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Tilray Brands

In other news, CEO Irwin D. Simon acquired 165,000 shares of Tilray Brands stock in a transaction on Wednesday, July 30th. The shares were purchased at an average price of $0.61 per share, with a total value of $100,650.00. Following the acquisition, the chief executive officer owned 3,941,633 shares in the company, valued at $2,404,396.13. This represents a 4.37% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.84% of the company’s stock.

Tilray Brands Stock Up 0.7%

NASDAQ TLRY opened at $1.49 on Monday. The firm has a market cap of $1.67 billion, a PE ratio of -0.66 and a beta of 1.98. Tilray Brands, Inc. has a one year low of $0.35 and a one year high of $2.32. The stock’s 50 day simple moving average is $1.38 and its 200 day simple moving average is $0.83. The company has a debt-to-equity ratio of 0.15, a current ratio of 2.62 and a quick ratio of 1.56.

Tilray Brands (NASDAQ:TLRY) last released its quarterly earnings results on Thursday, October 9th. The company reported $0.00 EPS for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.03. Tilray Brands had a negative return on equity of 6.79% and a negative net margin of 258.54%.The business had revenue of $209.50 million for the quarter, compared to analyst estimates of $205.75 million. As a group, sell-side analysts forecast that Tilray Brands, Inc. will post -0.2 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have commented on TLRY. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Tilray Brands in a report on Friday. Atb Cap Markets cut Tilray Brands from a “hold” rating to a “strong sell” rating in a report on Thursday, October 9th. Wall Street Zen raised Tilray Brands from a “strong sell” rating to a “hold” rating in a report on Saturday, October 11th. Jefferies Financial Group lifted their price objective on Tilray Brands from $1.50 to $2.00 and gave the company a “buy” rating in a report on Monday, August 25th. Finally, Zelman & Associates reaffirmed a “neutral” rating on shares of Tilray Brands in a report on Tuesday, July 29th. Two research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $2.00.

Tilray Brands Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.